Duration of Immune Response to Influenza Vaccination in Patients With RA

PHASE4CompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

February 29, 2016

Conditions
Rheumatoid Arthritis
Interventions
BIOLOGICAL

Influenza vaccine

"Each participant will have a blood draw to measure the antibody titres influenza strains covered by the 2014-2015 influenza vaccine at three different time points:~Visit 1- Baseline/prior to vaccination Visit 2- 4-6 weeks post-vaccination Visit 3- end of influenza season (April-May)~At Visit 1, after the baseline blood draw, all participants will be vaccinated by Research staff in order to standardize the time from Baseline blood draw to vaccination. Participants aged 65 and older will be offered the extra strength version of the vaccine, which is usual care. Participants under the age of 65 will be given the usual strength vaccine. All patients will be given the intramuscular (IM) vaccine."

Trial Locations (1)

13326

Bassett Healthcare Network, Cooperstown

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

New York State Department of Health

OTHER_GOV

lead

Bassett Healthcare

OTHER

NCT02311855 - Duration of Immune Response to Influenza Vaccination in Patients With RA | Biotech Hunter | Biotech Hunter